Emerging Therapeutics for Human Disease, Sponsored by AAI Clin. Immunol. Comm.

Chair(s)

• 

  Samik Basu, MD (he/him/his)

  Chief Scientific Officer
  Cabaletta Bio
  Philadelphia, Pennsylvania, United States
• 

  H. Komori, PhD (she/her/hers)

  Head of Translational Medicine
  Uniquity Bio

Presentations:

• 12:30 PM - 12:35 PM US ET

  Introduction
  

  Introduction: H. Kiyomi Komori, PhD (she/her/hers) – Uniquity Bio
• 12:35 PM - 12:55 PM US ET

  Zasocitinib: A Case Study in AI-Enabled Precision Drug Discovery
  

  Speaker: Olusegun Onabajo – Takeda Pharmaceuticals Company Ltd
• 12:55 PM - 1:15 PM US ET

  The IND journey: Preclinical development of rese-cel
  

  Speaker: Jinmin Lee – Cabaletta Bio
• 1:15 PM - 1:35 PM US ET

  IgG proteolysis as a therapeutic strategy: From mechanism to proof of concept
  

  Speaker: Sofia Jarnum – Hansa Biopharma AB
• 1:35 PM - 1:55 PM US ET

  Tenet-style discovery: Moving R&D forward by looking at the clinic in reverse
  

  Speaker: Adnan Khan – Sanofi
• 1:55 PM - 2:30 PM US ET

  Panel Discussion